DC Funds
Latest statistics and disclosures from DC Funds's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TCRX, BRNS, HOWL, and represent 100.00% of DC Funds's stock portfolio.
- DC Funds has $1.3B in assets under management (AUM), dropping by -15.65%.
- Central Index Key (CIK): 0001869028
Tip: Access up to 7 years of quarterly data
Positions held by DC Funds consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for DC Funds
DC Funds holds 3 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tscan Therapeutics (TCRX) | 49.3 | $618M | 630k | 980.10 |
|
|
| Barinthus Biotherapeutics Pl Ads (BRNS) | 33.8 | $424M | 642k | 660.00 |
|
|
| Werewolf Therapeutics (HOWL) | 16.9 | $212M | 589k | 359.90 |
|
Past Filings by DC Funds
SEC 13F filings are viewable for DC Funds going back to 2021
- DC Funds 2026 Q2 filed Aug. 14, 2026
- DC Funds 2026 Q1 filed May 14, 2026
- DC Funds 2025 Q4 filed Feb. 13, 2026
- DC Funds 2025 Q3 filed Nov. 10, 2025
- DC Funds 2025 Q2 filed Aug. 14, 2025
- DC Funds 2025 Q1 filed May 14, 2025
- DC Funds 2024 Q4 filed Feb. 14, 2025
- DC Funds 2024 Q3 filed Nov. 14, 2024
- DC Funds 2024 Q2 filed Aug. 13, 2024
- DC Funds 2024 Q1 filed May 14, 2024
- DC Funds 2023 Q4 filed Feb. 13, 2024
- DC Funds 2023 Q3 filed Nov. 14, 2023
- DC Funds 2023 Q2 filed Aug. 10, 2023
- DC Funds 2023 Q1 filed May 15, 2023
- DC Funds 2022 Q4 filed Feb. 14, 2023
- DC Funds 2022 Q3 filed Nov. 14, 2022